Why do large breast cancers still present in a population offered screening?

International Journal of Cancer

Volumn 123, Issue 12, 2008, Pages 2907-2914

  Kricker, Anne ^a   Newman, Beth ^b   Gertig, Dorota M ^c   Goumas, Chris ^a   Armes, Jane ^d   Armstrong, Bruce K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Victorian Cervical Cytology Registry Melbourne   (Australia)

^d MATER HOSPITAL   (Australia)

Author keywords

Advanced breast cancer; BMI; Cancer grade; HRT; Mammogram detection

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER SCREENING; CANCER SIZE; CONTROLLED STUDY; FEMALE; HEALTH CARE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MEDICAL RECORDS; MENOPAUSE; MIDDLE AGED; NEW SOUTH WALES; ODDS RATIO; QUEENSLAND; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SOCIAL CLASS; VICTORIA;

EID: 57349169397     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23829     Document Type: Article

References (41)

1. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res 2007;9:R28.
2. Australian Institute of Health and Welfare, National Breast Cancer Centre. Breast cancer size and nodal status. Cancer monitoring series no. 2. Canberra: Australian Institute of Health and Welfare, 2001. Available at: http://www.aihw.gov.au/publications/index.cfm/title/7217. Accessed on June 2, 2008.
3. Australian Institute of Health and Welfare, National Breast Cancer Centre. Breast cancer survival by size and nodal status in Australia. Cancer series no. 39. Canberra: Australian Institute of Health and Welfare, 2007. Available at: http://www.aihw.gov.au/publications/index.cfm/title/10474. Accessed on June 2, 2008.
4. International Agency for Research on Cancer. Breast cancer screening. [7]. IARC handbooks of cancer prevention. Lyon: International Agency for Research on Cancer, 2002.
5. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000;11:955-63.
6. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R. Individual and combined effects of age, breast density and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
7. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, Key CR, Linver MN. Effects of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque. New Mexico. Radiology 1998;209:511-18.
8. Kavanagh AM, Cawson J, Byrnes GB, Giles GG, Marr G, Tong B, Gertig DM, Hopper JL. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev 2005;14:1060-4.
9. Hall HI, Coates RJ, Uhler RJ, Brinton LA, Gammon MD, Brogan D, Potischman N, Malone KE, Swanson CA. Stage of breast cancer in relation to body mass index and bra cup size. Int J Cancer 1999;82:23-7.
10. Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors and stage at diagnosis of breast cancer. Am J Epidemiol 2001;153:284-91.
11. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32.
12. Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 1992;22:207-19.
13. Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R, Beverly RK, Casso D, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 2004;96:1518-27.
14. White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004;96:1832-9.
15. Hahn KM, Bondy ML, Selvan M, Lund MJ, Liff JM, Flagg EW, Brinton LA, Porter P, Eley JW, Coates RJ. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol 2007;166:1035-44.
16. Department of Primary Industries and Energy and Department of Human Services and Health. Rural, remote and metropolitan areas classification. 1991 census edition. Canberra: Australian Government Publishing Service, 1994.
17. Australian Bureau of Statistics. Census of population and housing: socio-economic indexes for areas (SEIFA), Australia. Canberra: Australian Bureau of Statistics, 1998.
18. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
19. Norman SA, Localio AR, Zhou L, Weber AL, Coates RJ, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Lee NC, Nadel MR. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States). Cancer Causes Control 2006;17:921-9.
20. Swedish Organized Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007;109:2205-12.
21. Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 1995;142:813-19.
22. Winchester DP, Osteen RT, Menck HR. The national cancer data base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996;78:1838-43.
23. Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin PM, Piana L. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995;62:138-44.
24. Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-94.
25. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, et al. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev 2003;12:1175-81.
26. Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR. Relationship between menopausal hormone therapy and risk of ductal, lobular and ductal-lobular breast Carcinomas. Cancer Epidemiol Biomarkers Prev 2008;17:43-50.
27. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 2003;21:4314-21.
28. Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J. Breast tumors following combined hormone replacement therapy express favorable prognostic factors. Int J Cancer 2007;120:2202-7.
29. Oestreicher N, White E, Malone KE, Porter PL. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth? Breast Cancer Res Treat 2004;85:133-42.
30. Feigelson HS, Patel AV, Teras LR, Gansler T, Thun MJ, Calle EE. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer 2006;107:12-21.
31. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA. Obesity and outcomes in premenopausal and post-menopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1686-91.
32. Elmore JG, Carney PA, Abraham LA, Barlow WE, Egger JR, Fosse JS, Cutter GR, Hendrick RE, D'Orsi CJ, Paliwal P, Taplin SH. The association between obesity and screening mammography accuracy. Arch Intern Med 2004;164:1140-7.
33. Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL. The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 1998;78:1233-8.
34. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol 2000;29:629-36.
35. Li CI, Malone KE, Daling JR. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Cancer Causes Control 2006;17:695-703.
36. Jones BA, Kasi SV, Curnen MG, Owens PH, Dubrow R. Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 1997;146:394-404.
37. Ringberg A, Bageman E, Rose C, Ingvar C, Jernstrom H. Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 2006;119:2242-3.
38. Henson DE, Chu KC, Levine PH. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer 2003;98:908-17.
39. Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybittle JL, Elston CW. Survival of invasive breast cancer according to the Nottingham prognostic index in cases diagnosed in 1990-1999. Eur J Cancer 2007;43:1548-55.
40. Kavanagh AM, Giles GG, Mitchell H, Cawson JN. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen 2000;7:105-10.
41. Australian Institute of Health and Welfare. Breastscreen Australia monitoring report 2003-2004. Cancer series no. 36. Canberra: Australian Institute of Health and Welfare, 2007.